You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
小智港股覆盤 | 9月16日
今日,港股三大指數集體下跌。截止收盤,恆生指數跌0.89%,報18761點。國企指數跌1.36%,報6420點。恆生科技指數大跌2.65%,報3858點。市場約516只個股上漲,1131只個股下跌。成交額突破1239.43億港幣,和昨天同期相比增長51.42%。南下資金淨流入14.02億港幣。 盤面上,飲料板塊活躍。王朝酒業漲超8%;新絲路文旅、通天酒業、百威亞太等多股漲超3%;青島啤酒股份漲超1%。百威亞太午後升幅擴至2.52%,百威亞太區最大精釀工廠交付。 個人用品板塊活躍。中生聯合漲超25%;德寶集團控股漲超22%;中證國際漲超7%;霸王集團漲超3%;恆安國際漲超1%。 CRO板塊集體下挫。康龍化成跌超7%;金斯瑞生物科技跌超6%;方達控股跌超5%;泰格醫藥、昭衍新藥等多股跌超4%。國泰君安首予康龍化成“買入”評級,目標價70.31港元;金斯瑞生物科技附屬傳奇生物將於10月3日舉辦研發日。 互聯網醫療板塊多數下跌。阿裏健康跌超5%;平安好醫生跌超4%;鷹瞳科技-B、醫渡科技等多股跌超3%。鷹瞳科技-B:Airdoc-AIFUNDUS,(2.0)完成臨牀試驗且試驗數據結果優異。 uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account